Jifar Wakuma Wakene, Geneti Getachew Befekadu, Dinssa Sileshi Dubale
Department of Pharmacy, College of Health Sciences, Mattu University, Mettu, Ethiopia.
J Multidiscip Healthc. 2022 Aug 31;15:1933-1943. doi: 10.2147/JMDH.S377319. eCollection 2022.
COVID-19 is a pandemic disease that has led to inequitable supply and shortages of essential medicines worldwide due to decreased production capacity, export bans, and national stockpiling which are affecting the global pharmaceutical supply chain. Access to essential pharmaceuticals is dependent on well-functioning supply chain systems that move medicines from the manufacturer to end users at service delivery point.
To assess impact of Covid-19 pandemic disease on pharmaceutical shortages and supply disruptions for non-communicable diseases among public hospitals of South West, Oromia, Ethiopia.
A multi-institutional cross sectional study design was employed. Quantitative and qualitative methods were utilized concurrently to gather data from four public hospital warehouses, dispensaries, patients, and local health authorities from March 1-30, 2021 in Ilu-Ababor and Buno-Bedelle Zones, Oromia, Ethiopia. Data were analyzed by using SPSS (version 23.0). A semi-structured interview guide was used to gather qualitative information from key informants from DTC members, patients, and local health authorities and finally analyzed through thematic approach.
From six public hospitals in the two zones; cost of medicine increased more in Dedesa hospital compared to the other public hospital found in that zone and the effect of Covid-19 on essential medicines used for treatment of non-communicable diseases was less in Darimu Hospital. Stock status of PFSA and transportation were the major challenges during the procurement process due to Covid-19 pandemic disease. Among the EMs assessed at public hospitals, drugs used for cardiovascular diseases were out of stock for more than 90 days while anti-asthma drugs were out of stock for less than 40 days.
The availability of essential medicine was low and there was also poor inventory management practice in some of the public hospitals during Covid-19 pandemic in the study period.
新冠疫情是一种大流行病,由于生产能力下降、出口禁令和国家储备等因素影响了全球药品供应链,导致全球基本药物供应不均衡和短缺。获得基本药物依赖于运作良好的供应链系统,该系统将药品从制造商运送到服务提供点的最终用户手中。
评估新冠疫情对埃塞俄比亚奥罗米亚西南部公立医院非传染性疾病药品短缺和供应中断的影响。
采用多机构横断面研究设计。2021年3月1日至30日,在埃塞俄比亚奥罗米亚的伊卢-阿巴博尔和布诺-贝代勒地区,同时运用定量和定性方法,从四家公立医院的仓库、药房、患者和地方卫生当局收集数据。使用SPSS(版本23.0)进行数据分析。使用半结构化访谈指南从药品配送中心成员、患者和地方卫生当局等关键信息提供者那里收集定性信息,最后通过主题分析法进行分析。
在这两个地区的六家公立医院中;与该地区的其他公立医院相比,德德萨医院药品成本增加更多,而新冠疫情对达里穆医院用于治疗非传染性疾病的基本药物的影响较小。由于新冠疫情,预填充注射器的库存状况和运输是采购过程中的主要挑战。在公立医院评估的基本药物中,用于心血管疾病的药物缺货超过90天,而抗哮喘药物缺货少于40天。
在研究期间的新冠疫情期间,一些公立医院基本药物的可及性较低,库存管理实践也较差。